(Other name for: recombinant human papillomavirus nonavalent vaccine) or A vaccine used to prevent anal, cervical, vulvar, and vaginal cancer caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52 and 58 and genital warts caused by HPV types 6 and 11. Gardasil 9 is approved for use in males aged 9 to 15 years and females aged 9 to 26 years. It is a type of nonavalent vaccine (a vaccine that works against nine different viruses or other microorganisms). Also called recombinant human papillomavirus nonavalent vaccine.